RESEARCH PEPTIDE
Retatrutide
Investigational triple-receptor agonist for laboratory research. Not approved for human use.
Items are saved to your cart for review at checkout.
- Original laboratory report available
- COA / Batch Lookup
DESCRIPTION
About this compound.
Retatrutide is an investigational triple-receptor agonist designed to interact with three incretin-related pathways: GLP-1, GIP, and glucagon receptors. This multi-pathway profile is what makes the compound scientifically notable in metabolic research.
GLP-1 receptor activity is associated with appetite regulation, glucose-dependent insulin signaling, and delayed gastric emptying.
GIP receptor activity is involved in nutrient handling, insulin response, and adipose tissue signaling.
Glucagon receptor activity is associated with hepatic energy metabolism and increased energy expenditure pathways.
Retatrutide remains an investigational research compound and is not approved for human use.
SPECIFICATIONS
Research specifications.
Technical specifications
- SKU
- PSL-RT-10MG
- Compound
- Retatrutide
- Alternate Name
- LY3437943
- Class
- Triple receptor agonist
- Receptor Targets
- GLP-1, GIP, Glucagon
- Format
- Lyophilized powder
- Nominal Strength
- 10mg
- Laboratory-Reported Amount — Batch Black Top
- 13.03mg
- Laboratory-Reported Purity — Batch Black Top
- 99.805%
- Testing
- Per original laboratory report (selected lots)
- COA Status
- Third-Party Report Available
- Intended Use
- Laboratory research only
- Human Use
- Not approved for human use
TESTING & QUALITY
Independent third-party laboratory documentation is published for selected lots. Testing scope and results are shown on each original laboratory report.
COA / Batch Lookup →Batch Testing — Black Top
Testing scope and results are shown on each original laboratory report. Results are batch-specific and do not apply to other lots.
- SKU
- PSL-RT-10MG
- Laboratory
- Janoshik
- Batch
- Black Top
- Task Number
- 199788
- Identity Result
- Retatrutide
- Laboratory-Reported Amount
- 13.03mg
- Laboratory-Reported Purity
- 99.805%
- Analysis Date
- July 8, 2026
Nominal Strength
10mg
Labeled vial strength
Laboratory-Reported Amount — Batch Black Top
13.03mg
Amount reported for the tested sample
Laboratory results apply only to the tested sample and batch identified above.
Use the unique verification key shown on the original report.
This third-party laboratory report applies only to the specific sample and batch identified in the report. Results do not establish safety, efficacy, sterility, regulatory approval, or suitability for human use.
FAQ
Common questions.
No. Retatrutide is sold strictly for laboratory and research use only. It is not intended for human or animal consumption.
When a third-party laboratory report is published for your lot, it appears on this product page under Testing & Quality and in COA / Batch Lookup. Results apply only to the tested sample and batch identified in that report.
The vial is labeled at a nominal strength of 10mg. The laboratory-reported amount on the original report reflects the specific sample tested and may differ. Review the published report for the batch you received.
Retatrutide is an investigational compound. This page is for laboratory research and educational reference only. Not for human consumption, medical use, or therapeutic application.
Retatrutide
$69.99